Tim Anderson
Stock Analyst at Wolfe Research
(1.71)
# 2,080
Out of 4,415 analysts
7
Total ratings
100%
Success rate
12.96%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Downgrades: Peer Perform | n/a | $163.79 | - | 3 | Feb 22, 2023 | |
| MRK Merck & Co. | Upgrades: Outperform | $127 | $127.51 | -0.40% | 2 | Feb 22, 2023 | |
| NVS Novartis AG | Downgrades: Peer Perform | n/a | $97.27 | - | 1 | May 9, 2022 | |
| AZN AstraZeneca | Upgrades: Outperform | n/a | $76.35 | - | 1 | Sep 22, 2017 |
AbbVie
Feb 22, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $163.79
Upside: -
Merck & Co.
Feb 22, 2023
Upgrades: Outperform
Price Target: $127
Current: $127.51
Upside: -0.40%
Novartis AG
May 9, 2022
Downgrades: Peer Perform
Price Target: n/a
Current: $97.27
Upside: -
AstraZeneca
Sep 22, 2017
Upgrades: Outperform
Price Target: n/a
Current: $76.35
Upside: -